Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Specifically, retatrutide simultaneously activates three incretin and metabolic hormone receptors: GLP-1 (glucagon-like peptide-1) receptor promotes insulin secretion, reduces appetite, and slows gastric emptying [8] [9] GIP (glucose-dependent insulinotropic polypeptide) receptor enhances insulin release and may support fat metabolism [11] [12] Glucagon receptor preclinical and early clinical data suggest this may increase energy expenditure and promote hepatic fat breakdown, though glucagon receptor agonism can also raise blood glucose levels and the full implications in humans are still being characterised [5] [6] This triple mechanism of action is hypothesised to produce meaningful reductions in body weight by addressing multiple aspects of metabolic dysfunction
That might be 1 PM in London or 10 PM in Tokyo
Minimal response may warrant increasing by 50-100mcg
This medication works by mimicking a hormone that regulates appetite and food intake
Symptoms usually subside once the body stabilizes on a maintenance dose.
Muttenthaler, M., et al
US$ 20.63
US$ 20.22
US$ 28.89
US$ 22.68
US$ 29.23
US$ 19.98
US$ 29.89
US$ 23.81
US$ 21.65
